1. A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma Clark, Joseph I.; Singh, Jatinder; Ernstoff, Marc S.; Lao, Christopher D.; Flaherty, Lawrence E.; Logan, Theodore F.; Curti, Brendan; Agarwala, Sanjiv S.; Taback, Bret; Cranmer, Lee; Lutzky, Jose; Luna, Theresa L.; Aung, Sandra; Lawson, David H. 2018 Articles Cancer--ImmunotherapyInterleukin-2Melanoma--TreatmentEnzyme inhibitors
2. Cellular features predicting susceptibility to ferroptosis: insights from cancer cell-line profiling Viswanathan, Vasanthi 2015 Theses CancerEnzyme inhibitorsCell deathCytology
3. The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase Cross, Janet V.; Foss, Frank W.; Rady, Joshua M.; Macdonald, Timothy L.; Templeton, Dennis J. 2007 Articles Mitogen-activated protein kinasesEnzyme inhibitorsBiochemistryElectrophilesCytologyBiology
4. 2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect Michl, Josef; Ohlbaum, Diane J.; Silverstein, Samuel C. 1976 Articles MacrophagesEnzyme inhibitorsPhagocytosisCytologyMicrobiologyImmunology
5. 2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages II... Michl, Josef; Ohlbaum, Diane J.; Silverstein, Samuel C. 1976 Articles MacrophagesEnzyme inhibitorsAdenosine triphosphate--SynthesisPhagocytosisCytologyMicrobiologyImmunology